172 related articles for article (PubMed ID: 36395069)
1. Non-neutralizing monoclonal antibody targeting VP2 EF loop of Coxsackievirus A16 can protect mice from lethal attack via Fc-dependent effector mechanism.
Du R; An C; Yao X; Wang Y; Wang G; Gao F; Bian L; Hu Y; Liu S; Zhao Q; Mao Q; Liang Z
Emerg Microbes Infect; 2023 Dec; 12(1):2149352. PubMed ID: 36395069
[TBL] [Abstract][Full Text] [Related]
2. Chimeric enterovirus 71 virus-like particle displaying conserved coxsackievirus A16 epitopes elicits potent immune responses and protects mice against lethal EV71 and CA16 infection.
Luo J; Huo C; Qin H; Hu J; Lei L; Pan Z
Vaccine; 2021 Jul; 39(30):4135-4143. PubMed ID: 34116877
[TBL] [Abstract][Full Text] [Related]
3. Protection against lethal enterovirus 71 challenge in mice by a recombinant vaccine candidate containing a broadly cross-neutralizing epitope within the VP2 EF loop.
Xu L; He D; Li Z; Zheng J; Yang L; Yu M; Yu H; Chen Y; Que Y; Shih JW; Liu G; Zhang J; Zhao Q; Cheng T; Xia N
Theranostics; 2014; 4(5):498-513. PubMed ID: 24669278
[TBL] [Abstract][Full Text] [Related]
4. A Broadly Cross-protective Vaccine Presenting the Neighboring Epitopes within the VP1 GH Loop and VP2 EF Loop of Enterovirus 71.
Xu L; He D; Yang L; Li Z; Ye X; Yu H; Zhao H; Li S; Yuan L; Qian H; Que Y; Kuo Shih JW; Zhu H; Li Y; Cheng T; Xia N
Sci Rep; 2015 Aug; 5():12973. PubMed ID: 26243660
[TBL] [Abstract][Full Text] [Related]
5. A novel inactivated enterovirus 71 vaccine can elicit cross-protective immunity against coxsackievirus A16 in mice.
Yang L; Liu Y; Li S; Zhao H; Lin Q; Yu H; Huang X; Zheng Q; Cheng T; Xia N
Vaccine; 2016 Nov; 34(48):5938-5945. PubMed ID: 27771182
[TBL] [Abstract][Full Text] [Related]
6. A potential therapeutic neutralization monoclonal antibody specifically against multi-coxsackievirus A16 strains challenge.
Du R; Mao Q; Hu Y; Lang S; Sun S; Li K; Gao F; Bian L; Yang C; Cui B; Xu L; Cheng T; Liang Z
Hum Vaccin Immunother; 2019; 15(10):2343-2350. PubMed ID: 30735461
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus core particles containing multiple epitopes confer protection against enterovirus 71 and coxsackievirus A16 infection in mice.
Huo C; Yang J; Lei L; Qiao L; Xin J; Pan Z
Vaccine; 2017 Dec; 35(52):7322-7330. PubMed ID: 29129453
[TBL] [Abstract][Full Text] [Related]
8. A combination vaccine comprising of inactivated enterovirus 71 and coxsackievirus A16 elicits balanced protective immunity against both viruses.
Cai Y; Ku Z; Liu Q; Leng Q; Huang Z
Vaccine; 2014 May; 32(21):2406-12. PubMed ID: 24657161
[TBL] [Abstract][Full Text] [Related]
9. A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice.
Ku Z; Liu Q; Ye X; Cai Y; Wang X; Shi J; Li D; Jin X; An W; Huang Z
Vaccine; 2014 Jul; 32(34):4296-303. PubMed ID: 24950363
[TBL] [Abstract][Full Text] [Related]
10. Hexon-modified recombinant E1-deleted adenoviral vectors as bivalent vaccine carriers for Coxsackievirus A16 and Enterovirus 71.
Zhang C; Yang Y; Chi Y; Yin J; Yan L; Ku Z; Liu Q; Huang Z; Zhou D
Vaccine; 2015 Sep; 33(39):5087-94. PubMed ID: 26296491
[TBL] [Abstract][Full Text] [Related]
11. Identification of conserved neutralizing linear epitopes within the VP1 protein of coxsackievirus A16.
Shi J; Huang X; Liu Q; Huang Z
Vaccine; 2013 Apr; 31(17):2130-6. PubMed ID: 23499595
[TBL] [Abstract][Full Text] [Related]
12. Protection from lethal challenge in a neonatal mouse model by circulating recombinant form coxsackievirus A16 vaccine candidates.
Li J; Chang J; Liu X; Yang J; Guo H; Wei W; Zhang W; Yu XF
J Gen Virol; 2014 May; 95(Pt 5):1083-1093. PubMed ID: 24496826
[TBL] [Abstract][Full Text] [Related]
13. The compatibility of inactivated-Enterovirus 71 vaccination with Coxsackievirus A16 and Poliovirus immunizations in humans and animals.
Mao Q; Wang Y; Shao J; Ying Z; Gao F; Yao X; Li C; Ye Q; Xu M; Li R; Zhu F; Liang Z
Hum Vaccin Immunother; 2015; 11(11):2723-33. PubMed ID: 25715318
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of an inactivated bivalent vaccine for enterovirus 71 and coxsackievirus A16 in mice immunized intradermally.
Fan S; Liao Y; Jiang G; Wang L; Zhao H; Yu L; Xu X; Li D; Zhang Y; Li Q
Vaccine; 2021 Jan; 39(3):596-604. PubMed ID: 33342637
[TBL] [Abstract][Full Text] [Related]
15. Poorly neutralizing polyclonal antibody in vitro against coxsackievirus A16 circulating strains can prevent a lethal challenge in vivo.
Yao X; Mao Q; Li Y; Hao C; Bian L; Chen P; Gao F; Wu X; Lu W; Gao Q; Li X; Liang Z
Hum Vaccin Immunother; 2018 May; 14(5):1275-1282. PubMed ID: 29337652
[TBL] [Abstract][Full Text] [Related]
16. A bispecific broadly neutralizing antibody against enterovirus 71 and coxsackievirus A16 with therapeutic potential.
Zhou B; Xu L; Zhu R; Tang J; Wu Y; Su R; Yin Z; Liu D; Jiang Y; Wen C; You M; Dai L; Lin Y; Chen Y; Yang H; An Z; Fan C; Cheng T; Luo W; Xia N
Antiviral Res; 2019 Jan; 161():28-35. PubMed ID: 30419253
[TBL] [Abstract][Full Text] [Related]
17. Coxsackievirus A16-like particles produced in Pichia pastoris elicit high-titer neutralizing antibodies and confer protection against lethal viral challenge in mice.
Zhang C; Liu Q; Ku Z; Hu Y; Ye X; Zhang Y; Huang Z
Antiviral Res; 2016 May; 129():47-51. PubMed ID: 26902108
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of monovalent and bivalent vaccines against lethal Enterovirus 71 and Coxsackievirus A16 infection in newborn mice.
Sun S; Jiang L; Liang Z; Mao Q; Su W; Zhang H; Li X; Jin J; Xu L; Zhao D; Fan P; An D; Yang P; Lu J; Lv X; Sun B; Xu F; Kong W; Jiang C
Hum Vaccin Immunother; 2014; 10(10):2885-95. PubMed ID: 25483672
[TBL] [Abstract][Full Text] [Related]
19. Coxsackievirus A16: epidemiology, diagnosis, and vaccine.
Mao Q; Wang Y; Yao X; Bian L; Wu X; Xu M; Liang Z
Hum Vaccin Immunother; 2014; 10(2):360-7. PubMed ID: 24231751
[TBL] [Abstract][Full Text] [Related]
20. In Vitro Characterization of Neutralizing Hen Antibodies to
Mwale PF; Lee CH; Huang PN; Tseng SN; Shih SR; Huang HY; Leu SJ; Huang YJ; Chiang LC; Mao YC; Wang WC; Yang YY
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33923724
[No Abstract] [Full Text] [Related]
[Next] [New Search]
